Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    VMAT2
Show Display Options
Rank Status Study
1 Completed 18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET Imaging
Condition: Parkinson's Disease
Intervention: Drug: 18F-DTBZ
2 Recruiting (+)-Alpha-Dihydrotetrabenazine Phase I
Condition: Healthy Subjects
Intervention: Drug: HTBZ
3 Active, not recruiting Evaluation of 18F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
Conditions: Healthy Volunteers;   Diabetes Mellitus, Type 1
Interventions: Drug: 18F-FP-DTBZ;   Radiation: PET Scanning
4 Completed PET Scan Imaging of Beta Cell Mass
Conditions: Type 1 Diabetes;   Obesity

Indicates status has not been verified in more than two years